You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Consensus Pathology Recommendations for Complex Malignant Hematology – December 2016

ID: GL-C50-28 déc 2016
Type of Content: Guidelines & Advice, Recommendation Report
Document Status: Current
Authors:
Pathology Complex Malignant Hematology Working Group

Guideline Objective

To provide direction for the standardization of laboratory services for diagnosis, treatment and follow-up of patients with acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, high-grade lymphoma and aplastic anemia. These recommendations provide guidance for the classification, diagnosis, work-up, turn-around-time and minimal residual disease testing for leukemia patients.

Intended Guideline Users

Physicians and Health Care Administrators

pdf download Full Report (PDF) (628.49 Ko)